Literature DB >> 20705789

The effect of ketamine anesthesia on the immune function of mice with postoperative septicemia.

Tetsuya Takahashi1, Manabu Kinoshita, Satoshi Shono, Yoshiko Habu, Takahiro Ogura, Shuhji Seki, Tomiei Kazama.   

Abstract

BACKGROUND: It is unknown how ketamine anesthesia immunologically affects the outcome of patients with postoperative septicemia. We investigated the effects of ketamine anesthesia on mice with an Escherichia coli or lipopolysaccharide (LPS) challenge after laparotomy, focusing on phagocytosis by liver macrophages (Kupffer cells) and cytokine production.
METHODS: C57BL/6 mice received ketamine or sevoflurane anesthesia during laparotomy, which was followed by an E. coli or LPS challenge; thereafter, mouse survival rates and cytokine secretions were examined. The effects of a β-adrenoceptor antagonist, nadolol, on ketamine anesthesia were also assessed to clarify the mechanisms of ketamine-induced immunosuppressive effects.
RESULTS: Ketamine anesthesia increased the mouse survival rate after LPS challenge after laparotomy compared with sevoflurane anesthesia, whereas such an effect of ketamine was not observed after E. coli challenge. Ketamine suppressed tumor necrosis factor (TNF) and interferon (IFN)-γ secretion after LPS and E. coli challenge. When bacterial growth was inhibited using an antibiotic, ketamine anesthesia effectively improved mouse survival after E. coli challenge compared with sevoflurane anesthesia. Neutralization of TNF also improved survival and decreased IFN-γ secretion after bacterial challenge in antibiotic-treated mice with sevoflurane anesthesia, suggesting that ketamine's suppression of TNF may improve survival. Ketamine also suppressed in vivo phagocytosis of microspheres by Kupffer cells in LPS-challenged mice. Concomitant use of nadolol with an anesthetic dose of ketamine did not restore TNF suppression in LPS-challenged mice, suggesting a mechanism independent of the β-adrenergic pathway. However, it restored TNF secretion under low-dose ketamine (10% anesthetic dose). In contrast, nadolol restored the decrease in phagocytosis by Kupffer cells, which was induced by the anesthetic dose of ketamine via the β-adrenergic pathway, suggesting distinct mechanisms.
CONCLUSION: Ketamine suppresses TNF production and phagocytosis by Kupffer cells/macrophages. Therefore, unless bacterial growth is well controlled (by an antibiotic), postoperative infection might not improve despite reduction of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705789     DOI: 10.1213/ANE.0b013e3181ed12fc

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  12 in total

1.  Effect of low-dose ketamine on post-operative serum IL-6 production among elective surgical patients: a randomized clinical trial.

Authors:  Tonny Stone Luggya; Tony Roche; Lameck Ssemogerere; Andrew Kintu; John Mark Kasumba; Arthur Kwizera; Jose Vb Tindimwebwa
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

2.  Tumor necrosis factor-α receptor type 1, not type 2, mediates its acute responses in the kidney.

Authors:  Alexander Castillo; M Toriqul Islam; Minolfa C Prieto; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2012-03-28

3.  Combined general and regional anesthesia and effects on immune function in patients with benign ovarian tumors treated by laparoscopic therapy.

Authors:  Yong-Chong Cheng; Xiao-Bin Cheng; Xin-Jie Li; Feng-Zhao Wang; Zhi-Kui Li
Journal:  Int J Clin Exp Med       Date:  2013-09-01

4.  Sleeping to survive?: The impact of volatile anesthetics on mortality in sepsis.

Authors:  Evan D Kharasch; Craig M Coopersmith
Journal:  Anesthesiology       Date:  2013-10       Impact factor: 7.892

5.  Activation of the phagocyte NADPH oxidase/NOX2 and myeloperoxidase in the mouse brain during pilocarpine-induced temporal lobe epilepsy and inhibition by ketamine.

Authors:  Fatma Tannich; Asma Tlili; Coralie Pintard; Amina Chniguir; Bruno Eto; Pham My-Chan Dang; Ouajdi Souilem; Jamel El-Benna
Journal:  Inflammopharmacology       Date:  2019-10-30       Impact factor: 4.473

6.  Effects of Ketamine on Levels of Inflammatory Cytokines IL-6, IL-1β, and TNF-α in the Hippocampus of Mice Following Acute or Chronic Administration.

Authors:  Yanning Li; Ruipeng Shen; Gehua Wen; Runtao Ding; Ao Du; Jichuan Zhou; Zhibin Dong; Xinghua Ren; Hui Yao; Rui Zhao; Guohua Zhang; Yan Lu; Xu Wu
Journal:  Front Pharmacol       Date:  2017-03-20       Impact factor: 5.810

7.  Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus.

Authors:  Chun Yang; Tao Hong; Jiang Shen; Jie Ding; Xiong-Wei Dai; Zhi-Qiang Zhou; Jian-Jun Yang
Journal:  Exp Ther Med       Date:  2013-01-29       Impact factor: 2.447

8.  Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).

Authors:  Maarten Swartjes; Marieke Niesters; Lara Heij; Ann Dunne; Leon Aarts; Carla Cerami Hand; Hyung-Suk Kim; Michael Brines; Anthony Cerami; Albert Dahan
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

9.  Targeting the innate repair receptor to treat neuropathy.

Authors:  Albert Dahan; Michael Brines; Marieke Niesters; Anthony Cerami; Monique van Velzen
Journal:  Pain Rep       Date:  2016-08-09

10.  Effects of oxycodone on immune function in patients undergoing radical resection of rectal cancer under general anesthesia.

Authors:  Jia-Hua Cui; Wan-Wei Jiang; Ya-Jing Liao; Qing-Hui Wang; Min Xu; Yu Li
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.